MicroRNA (miR) is important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to colorectal cancer (CRC). Here, we determined that miR-23a is overexpressed in human colorectal cancer cell lines and tissues compared with that of normal cells. The stable over-expression of miR-23a in CRC cells was sufficient to promote cell proliferation in vitro and in vivo. Further studies showed that miR-23a can directly bind to the 3′untranslated region (3′UTR) of PDK4 mRNA and subsequently repress both the mRNA and protein expressions of PDK4. PDK4 negatively regulate CRC proliferation via suppressing PDH activity. Ectopic expression of PDK4 by transiently transfected with PDK4 vector encoding the entire coding sequence could reverse the effects of miR-23a on CRC proliferation. By this way, miR-23a promotes PDH activation and oxidative phosphorylation to generate sufficient ATP for cell proliferation. Our results illustrated that the up-regulation of miR-23a played an important role in CRC cell proliferation through direct repressing PDK4, suggesting a potential application of miR-23a in prognosis prediction and therapeutic application in CRC.
Introduction
Colorectal cancer is a digestive tract tumor that represents the third leading cause of cancer death worldwide, with 5-year overall survival rate ranging from 40% to 60% [1, 2] . Most CRC deaths have been associated with tumor cell proliferation, invasion and metastasis. So, understanding the underlying molecular mechanisms of CRC maliganacy is crucial significance in developing therapeutic strategies for advanced CRC patients.
MicroRNAs (miRNAs) are an abundant class of highly conserved, short, regulatory (about 22 nt) non-coding RNAs that are widely expressed in living organisms. They can act as post-transcriptional regulators by binding to complementary sequences in the 3′ untranslated regions (3′UTR) of target mRNAs, causing either mRNA molecule degradation or translational inhibition [3] . MiRNAs have diverse functions, including the regulation of cellular differentiation, proliferation, and apoptosis [4] . Increasing evidence supports that miRNAs are critical regulators of tumorigenesis and cancer progression, as well as useful diagnostic and prognostic marker in human cancers [5] [6] [7] . However, understanding of how miRNAs regulate cancer development and progression, particularly how they may affect cancer cells survival is far from adequate.
The coding gene of miR-23a is located at chromosome 19 at location p13. 13 . Increased expression of miR-23a has been reported to promote cancer growth in bladder cancer, gastric adenocarcinoma and colorectal cancer [8] [9] [10] [11] . In the present study, we report that miR-23a is overexpressed in CRC cell lines and tissues. We present here the first evidence that miR-23a is essential for CRC cell survival in vitro and in vivo, partially due to target pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4), which regulates the pyruvate dehydrogenase (PDH) activation and oxidative phosphorylation to generate sufficient ATP for cell proliferation. Our study provides experimental evidence that miR23a is a positive regulator in the CRC cell survival.
Material and methods

Tissue specimens and cell culture
Normal colon tissues and CRC samples were obtain with medical informed consent in the First Affiliated Hospital of Jinan University, Guangzhou. All of the colorectal cancer lines were obtained from the Shanghai Institute of Cell Biology, China Academy of Sciences (Shanghai, China). Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) with high glucose (Hyclone, Beijing, China) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C, 5% CO 2 . 
Plasmid constructs
Human full length PDK4 cDNA (NM_002612.3) was amplified by PCR amplification (5′-ATTGGATCCAGATGAAGGCGGCCCGCTTCGTGCT-3′; 5′-ATTCTCGAG TCACATGGCCACTTCTTTTGCCAG-3′) from HCT8 cell cDNA and subcloned into the pcDNA4HisMaxC (Invitrogen) vector. Flag-PDK4 expression plasmid series (described in Fig. 2g ) were generated by insert PDK4 cDNA fused with C-terminal PDK4 3′UTR into pFLAG-CMV™-1 Expression Vector (Sigma-Aldrich).
RNA extraction and Real-time PCR
Total RNA was extracted using Trizol Reagent (Invitrogen, USA) according to the manufacturer's protocol. For mRNA experiments, RNA samples were reverse transcribed using random hexamer primers in the presence of RNase inhibitor (Takara Bio, Shiga, Japan). For miRNA experiments, RNA samples were directly reverse transcribed using the One Step PrimeScript miRNA cDNA synthesis Kit (Takara Bio). qRT-PCR was performed with SYBR Premex EX Taq (Takara Bio) using the 7500 Sequence Detection System (Applied Biosystems, Foster City, CA). A relative quantification analysis was performed using the ΔΔCt method, with actin and RUN48 as endogenous references for mRNA and miRNA, respectively. Relative gene expression is presented as log (2 -ΔΔCt ). The following primers were used. PDK4: 5′-CAATGGCACAAGG AATCATAGAG-3′, 5′-ATCAGCATCCGAGTAGAAATACG-3′; RYBP: 5′-AGGAAAGGCACCTCCACCAGAAA-3′, 5′-GACGGTGACGTTGCCCACA GTTA-3′; p16INK4A: 5′-GCTTCCTGGACACGCTGGTGGTGCT −3′, 5′-TGCGGGCATGGTTACTGCCTCTGG −3′; Actin: 5′-GGCATCCTCACCC TGAAGTA −3′, 5′-ATCAGCATCCGAGTAGAAATACG −3′; miR-23a: ATCACATTGCCAGGGATTTCC; miR-27a: TTCACAGTGGCTAAGTTC CGC; miR-24-2: TGGCTCAGTTCAGCAGGAACAG; RUN48: 5′-AGTGA TGATGACCCCAGGTAACTC-3′; the reverse primer for miRNA was provided by One
Step PrimeScript miRNA cDNA synthesis Kit (Takara Bio).
Transiently transfection and retrovirus-mediated gene transfer
For transiently transfection, PDK4, siPDK4 (targeting sequence: TCAATGCTTCCAATGTGGCTT), miR-23a (Qiagen), miR-23a inhibitor (Qiagen), were transfected by lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The cells were further culture for 48 h and then collected for analysis. For expression of PDK4, Flag-PDK4 expression plasmid series (Described in Fig. 2g ) were transfected by lipofectamine 2000, at the same time, miR-23a or inhibitor was simultaneously transfected. After 48 h of cultivation, cells were collected for western blot.
Retrovirus carrying miR-23a-mimic and miR-23a-inhibitor, PDK4-cDNA, shPDK4 (targeting sequence: TCAATGCTTCCAATGTGGCTT) were prepared by Shanghai GenePharma Co (Shanghai, China). For infection, 2 × 10 5 cells were re-suspended in 100 μL medium containing retrovirus in 24-well culture plate. Infections were carried out for 6 h at 37 ℃, 5% CO 2 . After the end of infection, 400 μL medium was added. Knockdown or overexpression was verified by western blot after 4 and 2 days infection, respectively.
Cell proliferation assays
For cell proliferation assays, cells (5000 per well) were placed in 96-well plates; the following day, cells were transfected with 50 nM miR23a mimic, inhibitor, or a corresponding control. The 0-h time point was measured at the time of transfection. MTT assays were performed every 24 h after transfection for 3 days, and absorbance was read on a 
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Microplate Reader (Synergy™ 4 Hybrid, BioTek, Winooski, VT). For a second approach, cells (50,000 per well) were placed in 24-well plates; the following day, cells were transfected with 200 nM miR-23a mimic, inhibitor, or a corresponding control. The cell number was counted every 24 h after transfection for 3 days.
The soft agar colony formation assay
12-well culture plates were covered with a layer of 0.5% agar in medium supplemented with 20% FBS to prevent the attachment of the cells to the plastic substratum. Cell suspensions (500 cells per well) were prepared in 0.3% agar and poured into plates. The plates were incubated at 37 ℃ in a humid atmosphere of 5% CO 2 for 14 days. Colonies were counted using a dissecting microscope.
Bionformatic prediction of miR-23a target genes
Genes potentially controlled by miR-23a were identified with Target Scan (http://targetscan.org/). The parameters were set as follows: species = "Human", miRNA name = "hs-miR-23a".
3′UTR-conjugated miRNA reporter assay
PDK4 3′UTR sequence was amplified (5′-ATT GCTAGCAGGCAAAA GAAGTGGCCATGT-3′; 5′-ATTTCTAGACACATAGTGTAAACTAAGTTTT AATCC) and inserted into pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega). HCT8 cells (1.5 × 10 4 cells/100 μL/well)
were co-transfected with the 3′UTR pmirGLO plasmid (100 ng/well; Qiagen) and miR-23a (20 nM; Qiagen) or miR-23a inhibitor (100 nM; Qiagen) using the Attractene Reagent (Qiagen). The cells were collected at 48 h post-transfection, and luciferase activity was measured using the dual-luciferase reporter assay system (Promega, Madison, WI) in Microplate Reader (Synergy™ 4 Hybrid, BioTek, Winooski, VT). The relative luciferase activities as compared to non-target reporter-transfected cells are shown. Through site-directed mutagenesis, miR-23a seed-pairing sites in the PDK4 3′UTR region were changed using the following primer: 5′-ACAGCTTTCCAAGTGTGCTTAGAACGGTCAAAAG TGTCCTGGCAAGAG-3′.
Pyruvate, Acetyl CoA measurement and ATP generation measurement
The pyruvate and Acetyl CoA levels were determined by Pyruvate Assay Kit (Sigma-Aldrich) and Acetyl-Coenzyme A Assay Kit (SigmaAldrich) according to the manufacturers' instructions. ATP levels were determined by ATP Bioluminescence Assay Kit CLS II (Roche, Basel, Switzerland) according to the manufacturers' instructions.
The OCR analysis
Cells were seeded into XF24 cell culture microplates (Seahorse Bioscience) and transfected as described in figures, and 48 h later, OCRs were quantified using the XFe24 instrument (Seahorse Bioscience) according to the manufacturer's protocol. Cells were equilibrated for 1 h at 37°C in XF Assay Medium (Seahorse Bioscience) supplemented with 25 mM glucose and 1 mM sodium pyruvate (pH 7.4) before any measurement. Oligomycin (1 μM), FCCP (5 μM) and Rotenone (1 μM) mixture agents were injected to each well consecutively.
Tumorigenicity assays in nude mice
All animals were received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985) and according to our institutional ethical guidelines for animal experiments. Four-week-old male BalB/C athymic (nu/nu) nude mice were purchased from the animal center of Guangdong Province (Guangzhou, China) and kept under pathogen-free conditions in the Laboratory Animal Center, Jinan University. The animals were adapted to new conditions for 1 week before the experiments. An aliquot (1.5 × 10 7 / 200 μL) of stably transfected empty retrovirus (Control), miR-23a-encoded retrovirus (miR-23a) or miR-23a plus PDK4-encoded retrovirus cells in PBS were injected subcutaneously into rear flank of female BALB/c athymic nude mouse. Tumor growth was examined every two days over 27 days (n = 8 per group). The tumor volume was estimated according to the following formula: tumor volume (mm 3 ) = ab 2 /2, where a = the larger diameter and b = smaller diameter.
Western blot analysis
Cells were suspended in lysis buffer (50 mM Tris-Cl, pH8.0, 150 mM NaCl, 0.5 mM MgCl 2 , 10% glycerol, 1% Triton-X 100, 0.1% SDS) with protease inhibitor cocktail (Roche Diagnostics) on ice for 10 min. Samples were separated by 10% SDS-PAGE and transferred electrophoretically to a PVDF membrane. After blocking with 5% non-fat milk, membranes were probed with primary antibodies overnight at 4°C, 
Statistical analysis
Statistical analyses were performed with SPSS v. 19.0. Data were presented as mean ± SEM from three independent experiments. The data from qPCR of cell lines, cell proliferation and tumor volumes were analyzed by using two-way ANOVA. The others were analyzed by using two-tailed Student's t-test. p < 0.05 was considered statistically significant.
Results
miR-23a is overexpressed and promotes CRC cell growth in vitro
Given the limited understanding of the role of miR-23a in CRC, we examined miR-23a expression using quantitative real-time PCR (qRT-PCR) in a panel of human colorectal cancer cell lines. We determined that approximately 83% (10 of 12) of the cell lines had significantly increased miR-23a expression compared with that of immortalized human colorectal cells (Fig. 1a) . We further analyzed the levels of miR23a expression in 24 normal colon and 24 CRC tissues. As shown in Fig. 1b, miR-23a was significantly up-regulated in CRC than that in normal colon tissues. miR-23a is part of a functional cluster (miR-23a, miR-27a, miR-24-2) located on chromosome 19 that shares a common promoter [12] . miR-27a and miR-24-2 were also up-regulated in CRC cell lines (Supplemental Fig. 1a, b) .
To determine the functional relevance of miR-23a overexpression in colorectal cancer cells, we overexpressed or inhibited miR-23a and evaluated the cellular outcomes. Increased miR-23a expression (Supplemental Fig. 2a ) resulted in increased cell growth, as measured by MTT assay, in the colorectal cancer cell lines HCT8 and SW480 (Fig. 1c) . Conversely, inhibition of miR-23a (Supplemental Fig. 2b ) resulted in decreased cell growth (Fig. 1d) . As a second approach, we counted cell number directly to assay cell growth, the similar results as above upon miR-23a overexpression (Supplemental Fig. 2c) and 
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inhibition (Supplemental Fig. 2d ) were obserbed. To further investigate the effect of miR-23a in colorectal cancer cell growth, we measured the ability of miR-23a to influence colony formation under conditions of low cell density. miR-23a overexpression increased, whereas its inhibition decreased their ability to form colonies of HCT8 and SW480 cells lines (Fig. 1e) . These results indicated that overexpression miR23a was sufficient to promote colorectal cancer cell proliferation in vitro.
miR-23a negatively regulates PDK4 expression
To study the functional significance of miR-23a, we attempted to identify the target genes of miR-23a using computational algorithms. The 3′UTR of PDK4 mRNA contained complementary site for the binding region of miR-23a (Fig. 2a) . We cloned a 3′UTR fragment containing putative binding site into the downstream of luciferase open reading frame of pmirGLO control vector (Fig. 2b) . To identify the regulatory sequence in 3′UTR of PDK4, we established additional two reporters with mutated sequence in potential seed region (Fig. 2b) . miR-23a overexpression significantly reduce the luciferase activity of the reporter containing PDK4 3′UTR in SW480 cells, but this did not affect the luciferase activity of the empty vector control (Fig. 2c) . When compared with anti-miR-con-transfection, an induced luciferase activity was shown in cells transfected with miR-23a inhibitor (Fig. 2d) . Mutant containing mutated sequence in the miR-23a seed region partially canceled the negative effect of endogenous miR-23a (Fig. 2c) and prevented the effect of Anti-miR-23a treatment (Fig. 2d) . We analyzed the changes of PDK4 expression in CRC cell lines upon miR-23a modification and found that the overexpression of miR-23a resulted in significant reduction of PDK4 expression at the mRNA and protein levels in HCT8 and SW480 cell lines (Fig. 2e) . In contrast, miR-23a inhibition results in accumulation of PDK4 mRNA and protein (Fig. 2f) . To confirm the results, we repeated the experiment to examine whether miR-23a could inhibit PDK4 expression through potential seed region. We made expression plasmid vectors carrying PDK4, PDK4-3′UTRWT, or PDK4-3′ UTRMu and tested their expressions in SW480 cells. Results demonstrated that expression of PDK4-3′ UTRWT was inhibited by simultaneous introduction of miR-23a (Fig. 2g) . miR-23a inhibition inversely rescued the PDK4 level, revealing that the cellular miR-23a level negatively affected that of the PDK4 expression through its 3′ UTR seed sequence. Considering the role of miR-23a in proliferation, we also measured the miR-23a-27a-24-2 cluster targeting genes involved in proliferation, p16INK4A/miR24-2 [13] and RYBP/miR27a [14] . miR23a overexpression and knockdown did not affect the expression of these two genes (Supplemental Fig. 3a, d ). These lines of evidence collectively demonstrate that miR-23a recognizes and regulates PDK4 expression through specific binding to its mRNA 3′ UTR.
PDK4 negatively regulate CRC proliferation via suppressing PDH activity
The conversion of pyruvate to acetyl-CoA is catalyzed by pyruvate dehydrogenase (PDH), whose activity is suppressed by phosphorylation by PDH kinases (Pdks) [15] . PDK4 overexpression decreased PDH activity (increased the phosphorylated PDH protein) (Fig. 3a) . Whereas, knockdown of PDK4 increased PDH activity (decreased the phosphorylated PDH protein) (Fig. 3b) . Consequently, PDK4 overexpression increased intracellular pyruvate levels, reduced Acetly-CoA, oxygen consumption rate (OCR) and ATP production (Fig. 3c) . Whereas, PDK4 knockdown decreased intracellular pyruvate levels, increased AcetlyCoA, OCR and ATP production (Fig. 3d) . Furthermore, PDK4 overexpression reduced (Fig. 3e) but knockdown promoted (Fig. 3f ) cell proliferation and colony formation.
miR-23a regulates mitochondrial oxidative phosphorylation via suppressing PDK4 expression in CRC cells
miR-23a/PDK4 axis and the role of PDK4 in PDH activity promote us to assay the role of miR-23a in energy metabolism. miR-23a overexpression increased PDH activity (decreased the phosphorylated PDH protein), which can be abolished by PDK4 overexpression (Fig. 4a) . By contrast, miR-23a inhibition decreased PDH activity (increased the phosphorylated PDH protein), which can be rescued by PDK4 knockdown (Fig. 4b) . Consequently, miR-23a overexpression reduced intracellular pyruvate levels, increased Acetly-CoA, oxygen consumption rate (OCR) and ATP production, all of the effects can be partly abolished by PDK4 overexpression (Fig. 4c) . Whereas, miR-23a inhibition increased intracellular pyruvate levels, decreased Acetly-CoA, OCR and ATP production, which are partly rescued by PDK4 knockdown (Fig. 4d) . Furthermore, miR-23a overexpression promoted proliferation and colony formation, which can be reduced by PDK4 overexpression (Fig. 4e) ; whereas, miR-23a inhibition suppressed proliferation and colony formation, the effects were abolished by PDK4 knockdown (Fig. 4f) . These results indicated that miR-23a is required for PDH activity and mitochondrial oxidative phosphorylation to maintain energy homeostasis and proliferation via negatively regulate PDK4 expression in CRC cells.
miR-23a facilitated CRC cell tumor growth via targeting PDK4 in vivo
Next, we tested whether the miR-23a-PDK4 axis would promote colorectal cancer cells growth in vivo with xenografts. HCT8 and SW480 cells were infected with an empty retrovirus control, a retrovirus encoding miR-23a to overexpress miR-23a or both miR-23a and PDK4 overexpression. Cells were injected into the flanks of athymic nude mice and monitored over time. For both cell lines, the miR23a-overexpressing cells grew tumors at a faster rate compared with cells containing vector control (Fig. 5a, b) . At the time of sacrifice, miR23a-overexpressing tumors were significantly larger compared with vector controls (Fig. 5a, b) . However, miR-23a overexpressing-induced the faster growth were reduced by PDK4 overexpression. By contrast, miR-23a inhibition reduced CRC tumor growth; the effects can be partly abolished by PDK4 knockdown (Fig. 5c, d) . Finally, we isolated HCT8 engrafted tissues to verify the expression of miR-23a (Fig. 6a, c) and alteration of cell metabolism. miR-23a overexpression increased PDH activity, Acetly-CoA and ATP production, all of the effects can be partly abolished in PDK4 overexpression tissue cells (Fig. 6b) . By contrast, miR-23a inhibition decreased PDH activity, Acetly-CoA and ATP production, which were abolished by PDK4 knockdown (Fig. 6d) . Therefore, miR-23a effectively promoted colorectal cancer cell growth via targeting PDK4 in vivo.
Discussion
Colorectal cancer is the second leading cause of cancer death in the United States [16] . Colorectal cancer is a classic example of a tumor that progresses through multiple distinct stages in its evolution. Understanding the molecular mechanisms that regulate the transition from preinvasive to invasive colorectal cancer is critical to the development of novel approaches to arrest tumor progression and improve outcomes of patients with colorectal cancer.
Recent studies have revealed that miRNAs act as an important regulator of gene expression at the post-transcriptional level and regulates a wide range of physiological and developmental processes [17] [18] [19] . Over the past several years, it has become clear that deregulated of miRNAs contribute to the development of most human cancers such as gastric cancer, bladder cancer and breast cancer, which they act as either oncogenes or tumor suppressors [20, 21] . Although several miRNAs have been shown to play important roles in the carcinogenesis and progress of colorectal cancer, the function of miR-23a in CRC remains unclear. In the current study, we investigated the role of miR23a in human CRC proliferation, we uncovered that miR-23a expression was significantly up-regulated in CRC cell lines and patients tissues. Furthermore, our results indicated that ectopic expression of miR-23a can promote cell proliferation and colony formation efficiency; it also can increase tumor cell growth in engratment mouse model in vivo. PDK4 was identified as a critical downstream target of miR-23a. We conclude that miR-23a may have pre-tumor growth function and the increased expression of miR-23a might play a pivotal role in the progression and development of colorectal cancer.
To explore the molecular mechanism by which miR-23a suppresses CRC cell growth, we identified PDK4 as a direct target of miR-23a in CRC cells. We revealed that exogenous miR-23a downregulated the expression of PDK4 protein. Luciferase report assay identified that miR23a is a novel miRNA that directly binds to PDK4 mRNA 3′UTR, expression of miR-23a in CRC cells led to a significant down-regulation of PDK4 mRNA and protein expression, miR-23a-induced cell proliferation were reversed by PDK4 overexpression. PDK4 protein is located in the matrix of the mitochondria and inhibits the pyruvate dehydrogenase complex by phosphorylating one of its subunits, reducing the conversion of pyruvate, which is produced from the oxidation of glucose and amino acids, to acetyl-CoA and contributing to the regulation of glucose metabolism [22] . The PDH complex must be tightly regulated due to its central role in general metabolism. Within the complex, there are three serine residues on the E1 component that are sites for phosphorylation; this phosphorylation inactivates the complex [23] . Our analysis also demonstrated that miR-23a regulates PDH activity, pyruvate, acetlyCoA, oxygen consumption rate and ATP levels via targeting PDK4, indicating PDK4-PDH-mitochondrial oxidative phosphorylation regulation pathway is the downstream process of miR-23a. Taken together, these results established a functional connection between miR-23a and PDK4, and confirm that miR-23a functions as an pre-tumor miRNA in CRC cells by targeting PDK4.
In conclusion, our study indicates that miR-23a promote CRC cell survival by negatively regulating the PDK4 expression. Deregulation of miR-23a expression may be a biomarker for the prognosis of CRC patients. Our findings also underscore the clinical potential of miR-23a in CRC treatment and support the development of effective therapeutic Fig. 5. miR-23a regulates CRC cell  growth in vivo. (a, b) HCT8 and SW480 cells were infected with empty retrovirus (Control), miR-23a-encoded retrovirus (miR-23a) or miR-23a plus PDK4-encoded retrovirus. Cells were injected subcutaneously into the flanks of nude mice, and tumor volume was measured at intervals (**p < 0.01, ***p < 0.001, Two-way ANOVA test.) and tumor weight was measured (*p < 0.05, **p < 0.01, t-tests) at time of sacrifice. Representative pictures of tumors are shown. (c, d) HCT8 and SW480 cells were infected with empty retrovirus (Control), miR-23a inhibitor-encoded retrovirus (inhibitor) or miR-23a inhibitor plus shPDK4-encoded retrovirus. Cells were injected subcutaneously into the flanks of nude mice, and tumor volume was measured at intervals (* p < 0.05, ***p < 0.001, Two-way ANOVA test.) and tumor weight was measured (*p < 0.05, **p < 0.01, t-tests) at time of sacrifice. Representative pictures of tumors are shown.
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